DNLI
Denali Therapeutics Inc

1,854
Mkt Cap
$3.26B
Volume
22.00
52W High
$23.77
52W Low
$10.57
PE Ratio
-7.17
DNLI Fundamentals
Price
$21.43
Prev Close
$20.86
Open
$20.86
50D MA
$18.71
Beta
1.60
Avg. Volume
1.77M
EPS (Annual)
-$2.57
P/B
3.30
Rev/Employee
$0.00
$2,573.97
Loading...
Loading...
News
all
press releases
Aberdeen Group plc Buys 210,835 Shares of Denali Therapeutics Inc. $DNLI
Aberdeen Group plc grew its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 23.4% in the third quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Denali Therapeutics (DNLI) Expected to Announce Earnings on Thursday
Denali Therapeutics (NASDAQ:DNLI) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...
MarketBeat·6d ago
News Placeholder
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Get Free Report) have earned an average recommendation of "Buy" from the fourteen brokerages that are presently covering the company, Marketbeat.com...
MarketBeat·11d ago
News Placeholder
Principal Financial Group Inc. Purchases 198,207 Shares of Denali Therapeutics Inc. $DNLI
Principal Financial Group Inc. boosted its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 18.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·16d ago
News Placeholder
Denali Therapeutics (NASDAQ:DNLI) Earns Buy Rating from BTIG Research
BTIG Research restated a "buy" rating and issued a $32.00 price target on shares of Denali Therapeutics in a report on Friday...
MarketBeat·19d ago
News Placeholder
Denali Therapeutics Showcases ETV Data at WORLD: TIVI PDUFA Near, DNL126 Hits 80% CSF Drop
Denali Therapeutics (NASDAQ:DNLI) used an analyst call from the 2026 WORLD Symposium in San Diego to highlight new and updated data from its enzyme transport vehicle (ETV) franchise, including...
MarketBeat·19d ago
News Placeholder
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
Let us look at some drug/biotech stocks, ZTS, PCRX, APLS, ACAD and DNLI, which are poised to beat on fourth-quarter 2025 earnings.
Zacks·22d ago
News Placeholder
Denali Therapeutics (NASDAQ:DNLI) Shares Up 11.3% - Here's Why
Denali Therapeutics (NASDAQ:DNLI) Shares Up 11.3% - Still a Buy...
MarketBeat·1mo ago
News Placeholder
Denali Therapeutics Inc. (NASDAQ:DNLI) Given Average Rating of "Buy" by Brokerages
Denali Therapeutics Inc. (NASDAQ:DNLI - Get Free Report) has earned an average recommendation of "Buy" from the sixteen ratings firms that are covering the company, MarketBeat reports. One research...
MarketBeat·1mo ago
News Placeholder
Campbell & CO Investment Adviser LLC Purchases 74,066 Shares of Denali Therapeutics Inc. $DNLI
Campbell & CO Investment Adviser LLC raised its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 51.9% in the 3rd quarter, according to the company in its most recent filing with...
MarketBeat·1mo ago
<
1
2
...
>

Latest DNLI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.